Pharmaceutical nanocrystals: production by wet milling and applications M Malamatari, KMG Taylor, S Malamataris, D Douroumis, K Kachrimanis Drug Discovery Today 23 (3), 534-547, 2018 | 275 | 2018 |
Preparation of carbamazepine–Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug–polymer miscibility by thermodynamic model fitting J Djuris, I Nikolakakis, S Ibric, Z Djuric, K Kachrimanis European Journal of Pharmaceutics and Biopharmaceutics 84 (1), 228-237, 2013 | 258 | 2013 |
Pharmaceutical cocrystals: New solid phase modification approaches for the formulation of APIs A Karagianni, M Malamatari, K Kachrimanis Pharmaceutics 10 (1), 18, 2018 | 227 | 2018 |
Co-amorphous solid dispersions for solubility and absorption improvement of drugs: Composition, preparation, characterization and formulations for oral delivery A Karagianni, K Kachrimanis, I Nikolakakis Pharmaceutics 10 (3), 98, 2018 | 182 | 2018 |
Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component S Kiortsis, K Kachrimanis, T Broussali, S Malamataris European journal of pharmaceutics and biopharmaceutics 59 (1), 73-83, 2005 | 145 | 2005 |
Solubility enhancement of desloratadine by solid dispersion in poloxamers N Kolašinac, K Kachrimanis, I Homšek, B Grujić, Z Đurić, S Ibrić International journal of pharmaceutics 436 (1-2), 161-170, 2012 | 129 | 2012 |
Quantitative analysis of paracetamol polymorphs in powder mixtures by FT-Raman spectroscopy and PLS regression K Kachrimanis, DE Braun, UJ Griesser Journal of pharmaceutical and biomedical analysis 43 (2), 407-412, 2007 | 117 | 2007 |
Spray drying for the preparation of nanoparticle-based drug formulations as dry powders for inhalation M Malamatari, A Charisi, S Malamataris, K Kachrimanis, I Nikolakakis Processes 8 (7), 788, 2020 | 99 | 2020 |
Controlled release of 5-fluorouracil from microporous zeolites M Spanakis, N Bouropoulos, D Theodoropoulos, L Sygellou, S Ewart, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 197-205, 2014 | 99 | 2014 |
Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming P Barmpalexis, K Kachrimanis, E Georgarakis European Journal of Pharmaceutics and Biopharmaceutics 77 (1), 122-131, 2011 | 93 | 2011 |
Dynamic moisture sorption and desorption of standard and silicified microcrystalline cellulose K Kachrimanis, MF Noisternig, UJ Griesser, S Malamataris European journal of pharmaceutics and biopharmaceutics 64 (3), 307-315, 2006 | 84 | 2006 |
Symbolic regression via genetic programming in the optimization of a controlled release pharmaceutical formulation P Barmpalexis, K Kachrimanis, A Tsakonas, E Georgarakis Chemometrics and Intelligent Laboratory Systems 107 (1), 75-82, 2011 | 83 | 2011 |
Crystallisation conditions and physicomechanical properties of ibuprofen–Eudragit® S100 spherical crystal agglomerates prepared by the solvent-change technique K Kachrimanis, G Ktistis, S Malamataris International journal of pharmaceutics 173 (1-2), 61-74, 1998 | 78 | 1998 |
Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling D Medarević, J Djuriš, S Ibrić, M Mitrić, K Kachrimanis International journal of pharmaceutics 540 (1-2), 150-161, 2018 | 76 | 2018 |
Artificial neural networks (ANNs) and modeling of powder flow K Kachrimanis, V Karamyan, S Malamataris International journal of pharmaceutics 250 (1), 13-23, 2003 | 71 | 2003 |
Improvement of aripiprazole solubility by complexation with (2-hydroxy) propyl-β-cyclodextrin using spray drying technique T Mihajlovic, K Kachrimanis, A Graovac, Z Djuric, S Ibric Aaps Pharmscitech 13, 623-631, 2012 | 70 | 2012 |
Tensile strength and disintegration of tableted silicified microcrystalline cellulose: Influences of interparticle bonding K Kachrimanis, I Nikolakakis, S Malamataris Journal of pharmaceutical sciences 92 (7), 1489-1501, 2003 | 68 | 2003 |
Spherical crystal agglomeration of ibuprofen by the solvent‐change technique in presence of methacrylic polymers K Kachrimanis, I Nikolakakis, S Malamataris Journal of pharmaceutical sciences 89 (2), 250-259, 2000 | 66 | 2000 |
Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation P Barmpalexis, FI Kanaze, K Kachrimanis, E Georgarakis European Journal of Pharmaceutics and Biopharmaceutics 74 (2), 316-323, 2010 | 65 | 2010 |
Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin D Medarević, K Kachrimanis, Z Djurić, S Ibrić European Journal of Pharmaceutical Sciences 78, 273-285, 2015 | 61 | 2015 |